Study of IFX-1 to Replace Steroids in Patients With Granulomatosis With Polyangiitis and Microscopic Polyangiitis.

NCT03895801 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

57

Enrollment

INDUSTRY

Sponsor class

Conditions

Granulomatosis With Polyangiitis (GPA)
Microscopic Polyangiitis (MPA)

Interventions

DRUG: IFX-1
DRUG: Placebo-IFX-1
DRUG: Glucocorticoid (GC)
DRUG: Placebo-Glucocorticoid (Placebo-GC)

Sponsor

InflaRx GmbH